Sveriges mest populära poddar
Talking Points
Vetenskap

Inflammatory Risk in Statin-Treated Patients

12 min•11 december 2024
Pooling data from the PROMINENT, REDUCE-IT, and STRENGTH trials, Paul Ridker and C. Michael Gibson discuss the residual inflammatory risks for patients treated with statins.

Fler avsnitt av Talking Points

Visa alla avsnitt av Talking Points
The PROCTOR Trial
•9 min
The SELUTION DeNovo Trial
•5 min
The VESALIUS-CV Trial
•7 min
The META-AF Trial
•5 min
Evolution of Pharmacotherapy in STEMI
•8 min
The CorCMR Trial
•6 min
The TUXEDO-2 Trial
•4 min
The FLOW Trial
•6 min
The 2024 ESC CCS Guidelines
•16 min
The My Heart Your Heart Trial
•6 min

Talking Points med TCTMD finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.